A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
Clinical trial NCT01572727 · COMPLETED
Trial details
- NCT number
- NCT01572727
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.